This patent covers a type of stem cell that has differentiated and is committed to the myeloid lineage. This stem cell is useful for inducing a rapid production of myeloid cells such as granulocytes and monocytes, which are protective against bacteria.
The cells covered in the patent display the phenotype of c-kit positive, negative for IL-7 receptor (most likely since IL-7 is associated with the lymphoid progenitors), and negative for markers of differentiated cells such as B220 (B cells), CD4 (T cells), CD8 (T cells), CD3 (T cells), Gr-1 (neutrophils) and Mac-1 (monocyte/macrophage).
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.